Neonatal livers: A source for the isolation of good-performing hepatocytes for cell transplantation

Cell Transplantation

Volumn 23, Issue 10, 2014, Pages 1229-1242

  Tolosa, Laia ^a   Pareja Ibars, Eugenia ^b   Teresa Donato, M ^a,c,d   Cortés, Miriam ^b   López, Silvia ^a   Jiménez, Nuria ^a   Mir, José ^b   Castell, José V ^a,c,d   Gómez Lechón, M José ^a,d  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adhesion molecules; Cryopreservation; Cytochrome P450; EpCAM; Neonatal hepatocytes; UDP glucuronosyltransferase; Ureogenesis

Indexed keywords

BETA CATENIN; BETA1 INTEGRIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; GLUCURONOSYLTRANSFERASE; UVOMORULIN;

ADULT; APOPTOSIS; ARTICLE; CELL ADHESION; CELL COUNT; CELL DEATH; CELL ISOLATION; CELL SURVIVAL; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; HEPATIC PROGENITOR CELL; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER PARENCHYMA; MALE; NEWBORN; ORGAN DONOR; QUALITY CONTROL; UREA CYCLE; CELL CULTURE; CELL SEPARATION; CYTOLOGY; ENZYMOLOGY; LIVER; LIVER TRANSPLANTATION; METABOLISM; PROCEDURES; TRANSPLANTATION;

CELL SEPARATION; CELLS, CULTURED; CRYOPRESERVATION; FEMALE; HEPATOCYTES; HUMANS; INFANT, NEWBORN; LIVER; LIVER TRANSPLANTATION; MALE;

EID: 84907967759     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368913X669743     Document Type: Article

References (65)

1. Allegaert, K.; Vanhaesebrouck, S.; Verbesselt, R.; van den Anker, J. N. In vivo glucuronidation activity of drugs in neonates: Extensive interindividual variability despite their young age. Ther. Drug Monit. 31(4):411–15; 2009.
2. Beath, S. V. Hepatic function and physiology in the newborn. Semin. Neonatol. 8(5):337–346; 2003.
3. Blake, M. J.; Castro, L.; Leeder, J. S.; Kearns, G. L. Ontogeny of drug metabolizing enzymes in the neonate. Semin. Fetal Neonatal Med. 10(2):123–138; 2005.
4. Blake, M. J.; Gaedigk, A.; Pearce, R. E.; Bomgaars, L. R.; Christensen, M. L.; Stowe, C.; James, L. P.; Wilson, J. T.; Kearns, G. L.; Leeder, J. S. Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin. Pharmacol. Ther. 81(4):510–516; 2007.
5. Bonora-Centelles, A.; Donato, M. T.; Lahoz, A.; Pareja, E.; Mir, J.; Castell, J. V.; Gomez-Lechon, M. J. Functional characterization of hepatocytes for cell transplantation: Customized cell preparation for each receptor. Cell Transplant. 19(1):21–28; 2010.
6. Brilliant, K. E.; Mills, D. R.; Callanan, H. M.; Hixson, D. C. Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C. Transplantation 88(4):486–495; 2009.
7. Brousseau, T.; Sharieff, G. Q. Newborn emergencies: The first 30 days of life. Pediatr. Clin. North Am. 53(1):69–84, vi; 2006.
8. Celton-Morizur, S.; Desdouets, C. Polyploidization of liver cells. Adv. Exp. Med. Biol. 676:123–135; 2010.
9. Choonara, I. A.; McKay, P.; Hain, R.; Rane, A. Morphine metabolism in children. Br. J. Clin. Pharmacol. 28(5):599–604; 1989.
10. Crespi, C. L.; Penman, B. W.; Leakey, J. A.; Arlotto, M. P.; Stark, A.; Parkinson, A.; Turner, T.; Steimel, D. T.; Rudo, K.; Davies, R. L.; Langenbach, R. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11(8):1293–1300; 1990.
11. Cresteil, T. Onset of xenobiotic metabolism in children: Toxicological implications. Food Addit. Contam. 15(Suppl): 45–51; 1998.
12. Cusick, R. A.; Lee, H.; Sano, K.; Pollok, J. M.; Utsunomiya, H.; Ma, P. X.; Langer, R.; Vacanti, J. P. The effect of donor and recipient age on engraftment of tissue-engineered liver. J. Pediatr. Surg. 32(2):357–360; 1997.
13. de Wildt, S. N.; Kearns, G. L.; Leeder, J. S.; van den Anker, J. N. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin. Pharmacokinet. 36(6):439– 452; 1999.
14. Dhawan, A.; Puppi, J.; Hughes, R. D.; Mitry, R. R. Human hepatocyte transplantation: Current experience and future challenges. Nat. Rev. Gastroenterol. Hepatol. 7(5):288–298; 2010.
15. Donato, M. T.; Castell, J. V.; Gomez-Lechon, M. J. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: Comparison with other hepatic cellular models. J. Hepatol. 31(3):542-549; 1999.
16. Donato, M. T.; Lahoz, A.; Montero, S.; Bonora, A.; Pareja, E.; Mir, J.; Castell, J. V.; Gomez-Lechon, M. J. Functional assessment of the quality of human hepatocyte preparations for cell transplantation. Cell Transplant. 17(10–11):1211–1219; 2008.
17. Donato, M. T.; Montero, S.; Castell, J. V.; Gomez-Lechon, M. J.; Lahoz, A. Validated assay for studying activity profiles of human liver UGTs after drug exposure: Inhibition and induction studies. Anal. Bioanal. Chem. 396(6):2251–2263; 2010.
18. Fitzpatrick, E.; Mitry, R. R.; Dhawan, A. Human hepatocyte transplantation: State of the art. J. Intern. Med. 266(4): 339–357; 2009.
19. Gomez-Lechon, M. J.; Castell, J. V.; Donato, M. T. An update on metabolism studies using human hepatocytes in primary culture. Expert Opin. Drug Metab. Toxicol. 4(7):837–854; 2008.
20. Gomez-Lechon, M. J.; Lahoz, A.; Castell, J. V.; Donato, M. T. Evaluation of cytochrome P450 activities in human hepatocytes in vitro. Methods Mol. Biol. 806:87–97; 2012.
21. Gómez-Lechón, M. J.; Lahoz, A.; Jiménez, N.; Castell, J. V.; Donato, M. T. Cryopreservation of rat, dog and human hepatocytes: Influence of preculture and cryoprotectants on recovery, cytochrome P450 activities and induction upon thawing. Xenobiotica 36:457–472; 2006.
22. Gómez-Lechón, M. J.; Lopez, P.; Donato, T.; Montoya, A.; Larrauri, A.; Gimenez, P.; Trullenque, R.; Fabra, R.; Castell, J. V. Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo. In Vitro Cell. Dev. Biol. 26(1):67–74; 1990.
23. Gómez-Lechón, M. J.; O’Connor, E.; Castell, J. V.; Jover, R. Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes. Toxicol. Sci. 65(2): 299–308; 2002.
24. Grondin, M.; Hamel, F.; Averill-Bates, D. A.; Sarhan, F. Wheat proteins enhance stability and function of adhesion molecules in cryopreserved hepatocytes. Cell Transplant. 18(1):79–88; 2009.
25. Hines, R. N. Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children. Int. J. Pharm. 452(1–2):3–7; 2013.
26. Hines, R. N. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol. Ther. 118(2):250–267; 2008.
27. Hines, R. N. Ontogeny of human hepatic cytochromes P450. J. Biochem. Mol. Toxicol. 21(4):169–175; 2007.
28. Hughes, R. D.; Mitry, R. R.; Dhawan, A. Current status of hepatocyte transplantation. Transplantation 93(4):342–347; 2012.
29. Johnsrud, E. K.; Koukouritaki, S. B.; Divakaran, K.; Brunengraber, L. L.; Hines, R. N.; McCarver, D. G. Human hepatic CYP2E1 expression during development. J. Pharmacol. Exp. Ther. 307(1):402–407; 2003.
30. Jorns, C.; Ellis, E. C.; Nowak, G.; Fischler, B.; Nemeth, A.; Strom, S. C.; Ericzon, B. G. Hepatocyte transplantation for inherited metabolic diseases of the liver. J. Intern. Med. 272(3):201–223; 2012.
31. Joshi, M.; Patil, P. B.; He, Z.; Holgersson, J.; Olausson, M.; Sumitran-Holgersson, S. Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes. Cytotherapy 14(6):657–669; 2012.
32. Kootstra, G.; Daemen, J. H.; Oomen, A. P. Categories of non-heart-beating donors. Transplant. Proc. 27(5):2893–2894; 1995.
33. Koukouritaki, S. B.; Manro, J. R.; Marsh, S. A.; Stevens, J. C.; Rettie, A. E.; McCarver, D. G.; Hines, R. N. Developmental expression of human hepatic CYP2C9 and CYP2C19. J. Pharmacol. Exp. Ther. 308(3):965–974; 2004.
34. Krekels, E. H.; Danhof, M.; Tibboel, D.; Knibbe, C. A. Ontogeny of hepatic glucuronidation; methods and results. Curr. Drug Metab. 13(6):728–743; 2012.
35. Lacroix, D.; Sonnier, M.; Moncion, A.; Cheron, G.; Cresteil, T. Expression of CYP3A in the human liver-- Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem. 247(2): 625–634; 1997.
36. Luebke-Wheeler, J. L.; Nedredal, G.; Yee, L.; Amiot, B. P.; Nyberg, S. L. E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transplant. 18(12):1281–1287; 2009.
37. McCarver, D. G.; Hines, R. N. The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms. J Pharmacol. Exp. Ther. 300(2): 361–366; 2002.
38. Meijer, A. J.; Lof, C.; Ramos, I. C.; Verhoeven, A. J. Control of ureogenesis. Eur. J. Biochem. 148(1):189–196; 1985.
39. Meyburg, J.; Alexandrova, K.; Barthold, M.; Kafert- Kasting, S.; Schneider, A. S.; Attaran, M.; Hoerster, F.; Schmidt, J.; Hoffmann, G. F.; Ott, M. Liver cell transplantation: Basic investigations for safe application in infants and small children. Cell Transplant. 18(7):777–786; 2009.
40. Meyburg, J.; Das, A. M.; Hoerster, F.; Lindner, M.; Kriegbaum, H.; Engelmann, G.; Schmidt, J.; Ott, M.; Pettenazzo, A.; Luecke, T.; Bertram, H.; Hoffmann, G. F.; Burlina, A. One liver for four children: First clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87(5):636–641; 2009.
41. Miyagi, S. J.; Milne, A. M.; Coughtrie, M. W.; Collier, A. C. Neonatal development of hepatic UGT1A9: Implications of pediatric pharmacokinetics. Drug Metab. Dispos. 40(7): 1321–1327; 2012.
42. Oesterheld, J. R. A review of developmental aspects of cytochrome P450. J. Child Adolesc. Psychopharmacol. 8(3):161–174; 1998.
43. Ostrowska, A.; Bode, D. C.; Pruss, J.; Bilir, B.; Smith, G. D.; Zeisloft, S. Investigation of functional and morphological integrity of freshly isolated and cryopreserved human hepatocytes. Cell Tissue Bank 1(1):55–68; 2000.
44. Pinkse, G. G.; Voorhoeve, M. P.; Noteborn, M.; Terpstra, O. T.; Bruijn, J. A.; De Heer, E. Hepatocyte survival depends on beta1-integrin-mediated attachment of hepatocytes to hepatic extracellular matrix. Liver Int. 24(3):218–226; 2004.
45. Puppi, J.; Strom, S. C.; Hughes, R. D.; Bansal, S.; Castell, J. V.; Dagher, I.; Ellis, E. C.; Nowak, G.; Ericzon, B. G.; Fox, I. J.; Gomez-Lechon, M. J.; Guha, C.; Gupta, S.; Mitry, R. R.; Ohashi, K.; Ott, M.; Reid, L. M.; Roy-Chowdhury, J.; Sokal, E.; Weber, A.; Dhawan, A. Improving the techniques for human hepatocyte transplantation: Report from a consensus meeting in London. Cell Transplant. 21(1):1–10; 2012.
46. Ribes-Koninckx, C.; Pareja Ibars, E.; Agrasot, M. A.; Bonora-Centelles, A.; Polo Miquel, B.; Vila Carbo, J. J.; Donat Aliaga, E.; Mir Pallardo, J.; Gomez-Lechon, M. J.; Castell, J. V. Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Cell Transplant. 21(10):2267–2282; 2012.
47. Rodeiro, I.; Gomez-Lechon, M. J.; Perez, G.; Hernandez, I.; Herrera, J. A.; Delgado, R.; Castell, J. V.; Donato, M. T. Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes. Phytother. Res. 27:745–752; 2013.
48. Schmelzer, E.; Wauthier, E.; Reid, L. M. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 24(8): 1852–1858; 2006.
49. Schmelzer, E.; Zhang, L.; Bruce, A.; Wauthier, E.; Ludlow, J.; Yao, H. L.; Moss, N.; Melhem, A.; McClelland, R.; Turner, W.; Kulik, M.; Sherwood, S.; Tallheden, T.; Cheng, N.; Furth, M. E.; Reid, L. M. Human hepatic stem cells from fetal and postnatal donors. J. Exp. Med. 204(8):1973–1987; 2007.
50. Stephenne, X.; Najimi, M.; Ngoc, D. K.; Smets, F.; Hue, L.; Guigas, B.; Sokal, E. M. Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transplant. 16(4):409–419; 2007.
51. Stephenne, X.; Najimi, M.; Sibille, C.; Nassogne, M. C.; Smets, F.; Sokal, E. M. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130(4): 1317–1323; 2006.
52. Stevens, J. C.; Hines, R. N.; Gu, C.; Koukouritaki, S. B.; Manro, J. R.; Tandler, P. J.; Zaya, M. J. Developmental expression of the major human hepatic CYP3A enzymes. J. Pharmacol. Exp. Ther. 307(2):573–582; 2003.
53. Strassburg, C. P.; Strassburg, A.; Kneip, S.; Barut, A.; Tukey, R. H.; Rodeck, B.; Manns, M. P. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50(2):259–265; 2002.
54. Suzuki, A.; Taniguchi, H.; Zheng, Y. W.; Takada, Y.; Fukunaga, K.; Seino, K.; Yazawa, K.; Otsuka, M.; Yoshiki, A.; Kusakabe, M.; Fukao, K.; Nakauchi, H. Proliferative and functional ability of transplanted murine neonatal hepatocytes in adult livers. Transplant. Proc. 32(7):2370–2371; 2000.
55. Tateishi, T.; Nakura, H.; Asoh, M.; Watanabe, M.; Tanaka, M.; Kumai, T.; Takashima, S.; Imaoka, S.; Funae, Y.; Yabusaki, Y.; Kamataki, T.; Kobayashi, S. A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci. 61(26):2567–2574; 1997.
56. Terry, C.; Dhawan, A.; Mitry, R. R.; Lehec, S. C.; Hughes, R. D. Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl. 16(2):229–237; 2010.
57. Terry, C.; Dhawan, A.; Mitry, R. R.; Lehec, S. C.; Hughes, R. D. Preincubation of rat and human hepatocytes with cytoprotectants prior to cryopreservation can improve viability and function upon thawing. Liver Transpl. 12(1):165–177; 2006.
58. Terry, C.; Hughes, R. D.; Mitry, R. R.; Lehec, S. C.; Dhawan, A. Cryopreservation-induced nonattachment of human hepatocytes: Role of adhesion molecules. Cell Transplant. 16(6):639–647; 2007.
59. Tolosa, L.; Bonora-Centelles, A.; Donato, M. T.; Mirabet, V.; Pareja, E.; Negro, A.; Lopez, S.; Castell, J. V.; Gomez- Lechon, M. J. Influence of platelet lysate on the recovery and metabolic performance of cryopreserved human hepatocytes upon thawing. Transplantation 91(12):1340–1346; 2011.
60. Treluyer, J. M.; Gueret, G.; Cheron, G.; Sonnier, M.; Cresteil, T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: In-vivo/ in-vitro correlation and inducibility. Pharmacogenetics 7(6): 441–452; 1997.
61. Vieira, I.; Sonnier, M.; Cresteil, T. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 238(2):476–483; 1996.
62. Watchko, J. F.; Daood, M. J.; Biniwale, M. Understanding neonatal hyperbilirubinaemia in the era of genomics. Semin. Neonatol. 7(2):143–152; 2002.
63. Zaya, M. J.; Hines, R. N.; Stevens, J. C. Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab. Dispos. 34(12):2097–2101; 2006.
64. Zhang, L.; Theise, N.; Chua, M.; Reid, L. M. The stem cell niche of human livers: Symmetry between development and regeneration. Hepatology 48(5):1598–1607; 2008.
65. Zhang, Z. G.; Li, X. B.; Gao, L.; Liu, G. W.; Kong, T.; Li, Y. F.; Wang, H. B.; Zhang, C.; Wang, Z.; Zhang, R. H. An updated method for the isolation and culture of primary calf hepatocytes. Vet. J. 191(3):323–326; 2012.